0001225208-22-003299.txt : 20220224 0001225208-22-003299.hdr.sgml : 20220224 20220224162153 ACCESSION NUMBER: 0001225208-22-003299 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220222 FILED AS OF DATE: 20220224 DATE AS OF CHANGE: 20220224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pierce David A CENTRAL INDEX KEY: 0001529751 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 22671325 MAIL ADDRESS: STREET 1: BOSTON SCIENTIFIC CORPORATION STREET 2: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 4 1 doc4.xml X0306 4 2022-02-22 0000885725 BOSTON SCIENTIFIC CORP BSX 0001529751 Pierce David A 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 EVP Pres MedSurg Common Stock 2022-02-22 4 S 0 1884.0000 42.5500 D 1761.0000 D Common Stock 2022-02-23 4 S 0 1761.0000 43.2800 D 0.0000 D Performance Share Units 2022-02-22 4 A 0 17439.0000 0.0000 A 2023-12-31 2023-12-31 Common Stock 17439.0000 17439.0000 D The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock. On February 17, 2021, the reporting person was awarded a target number of performance share units under the Company's 2021 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2021 adjusted free cash flow measured against its 2021 financial plan over the one-year performance period ending December 31, 2021 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2022, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2023. /s/ Susan Thompson, Attorney-in-Fact 2022-02-23